SIMILAR PATTERNS OF AMINO ACIDS FOR 5W5V_A_ANWA701

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kp0 CREATINE
AMIDINOHYDROLASE

(Actinobacillus) 		PF00557
(Peptidase_M24)
PF01321
(Creatinase_N) 		5 LEU A 260
ALA A 170
GLY A 176
THR A 180
MET A 201
 None
 1.40A 5w5vA-1kp0A:
undetectable		 5w5vA-1kp0A:
18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxk MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  70
ALA A  91
VAL A 118
MET A 138
THR A 206
 STU  A 401 (-3.9A)
STU  A 401 (-3.4A)
None
STU  A 401 (-3.2A)
STU  A 401 (-3.2A)
 1.07A 5w5vA-1nxkA:
2.8		 5w5vA-1nxkA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r0l 1-DEOXY-D-XYLULOSE
5-PHOSPHATE
REDUCTOISOMERASE

(Zymomonas
mobilis) 		PF02670
(DXP_reductoisom)
PF08436
(DXP_redisom_C)
PF13288
(DXPR_C) 		5 LEU A  86
ALA A 109
GLY A  11
THR A  13
THR A  97
 None
None
NDP  A 400 (-3.1A)
NDP  A 400 (-4.1A)
None
 1.23A 5w5vA-1r0lA:
undetectable		 5w5vA-1r0lA:
24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 616
ALA A 642
VAL A 675
CYH A 694
GLY A 697
 None
 0.49A 5w5vA-1rjbA:
13.4		 5w5vA-1rjbA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 595
ALA A 621
VAL A 654
CYH A 673
GLY A 676
 STI  A   3 ( 3.8A)
STI  A   3 (-3.5A)
STI  A   3 (-4.3A)
STI  A   3 (-4.5A)
STI  A   3 ( 3.8A)
 0.71A 5w5vA-1t46A:
10.4		 5w5vA-1t46A:
19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 344
ALA A 367
VAL A 399
MET A 414
GLY A 418
 STU  A 100 (-3.8A)
STU  A 100 (-3.2A)
None
STU  A 100 (-3.6A)
STU  A 100 ( 4.7A)
 1.25A 5w5vA-1u59A:
3.8		 5w5vA-1u59A:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 344
ALA A 367
VAL A 399
MET A 414
GLY A 420
 STU  A 100 (-3.8A)
STU  A 100 (-3.2A)
None
STU  A 100 (-3.6A)
STU  A 100 (-3.5A)
 0.48A 5w5vA-1u59A:
3.8		 5w5vA-1u59A:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xvx YFUA

(Yersinia
enterocolitica) 		PF13343
(SBP_bac_6) 		5 LEU A  60
ALA A  12
GLY A 232
THR A  99
MET A  67
 None
 1.44A 5w5vA-1xvxA:
undetectable		 5w5vA-1xvxA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  15
ALA A  36
VAL A  68
CYH A  87
GLY A  90
 HYM  A 400 (-4.2A)
HYM  A 400 (-3.5A)
HYM  A 400 (-4.8A)
HYM  A 400 (-4.2A)
None
 0.41A 5w5vA-1zltA:
14.1		 5w5vA-1zltA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy4 SERINE/THREONINE-PRO
TEIN KINASE GCN2

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 LEU A 605
ALA A 626
VAL A 656
MET A 788
CYH A 791
 None
GOL  A 998 ( 3.7A)
GOL  A 998 (-4.9A)
GOL  A 998 ( 4.2A)
GOL  A 998 (-4.3A)
 0.72A 5w5vA-1zy4A:
12.8		 5w5vA-1zy4A:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f2a ASPARTYL/GLUTAMYL-TR
NA(ASN/GLN)
AMIDOTRANSFERASE
SUBUNIT B

(Staphylococcus
aureus) 		PF02637
(GatB_Yqey)
PF02934
(GatB_N) 		5 LEU B  15
ALA B  59
VAL B 288
MET B  60
GLY B 178
 None
 1.46A 5w5vA-2f2aB:
undetectable		 5w5vA-2f2aB:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		5 ALA A 452
VAL A 484
MET A 499
CYH A 502
GLY A 505
 4ST  A1687 (-3.3A)
None
4ST  A1687 ( 3.9A)
4ST  A1687 (-4.1A)
4ST  A1687 (-3.2A)
 0.53A 5w5vA-2j0jA:
16.1		 5w5vA-2j0jA:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jkm FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF07714
(Pkinase_Tyr) 		5 ALA A 452
VAL A 484
MET A 499
CYH A 502
GLY A 505
 BII  A1687 (-3.5A)
None
BII  A1687 (-4.1A)
BII  A1687 (-4.1A)
BII  A1687 (-3.6A)
 0.49A 5w5vA-2jkmA:
11.9		 5w5vA-2jkmA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 588
ALA A 614
VAL A 647
CYH A 666
GLY A 669
 None
 0.41A 5w5vA-2ogvA:
8.6		 5w5vA-2ogvA:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 LEU A 344
ALA A 367
VAL A 399
MET A 414
GLY A 419
 ANP  A 615 (-4.4A)
ANP  A 615 (-3.3A)
None
ANP  A 615 ( 3.9A)
None
 0.78A 5w5vA-2ozoA:
15.6		 5w5vA-2ozoA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 LEU A 344
ALA A 367
VAL A 399
MET A 414
GLY A 420
 ANP  A 615 (-4.4A)
ANP  A 615 (-3.3A)
None
ANP  A 615 ( 3.9A)
ANP  A 615 ( 3.9A)
 0.85A 5w5vA-2ozoA:
15.6		 5w5vA-2ozoA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3g MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU X  70
ALA X  91
VAL X 118
MET X 138
THR X 206
 F10  X 401 (-3.9A)
F10  X 401 (-3.4A)
None
F10  X 401 ( 4.0A)
F10  X 401 (-3.8A)
 0.94A 5w5vA-2p3gX:
4.2		 5w5vA-2p3gX:
16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r4b RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 724
ALA A 749
VAL A 781
GLY A 802
THR A 860
 GW7  A   1 ( 4.2A)
GW7  A   1 (-3.3A)
GW7  A   1 ( 4.7A)
GW7  A   1 (-3.6A)
GW7  A   1 (-3.5A)
 0.82A 5w5vA-2r4bA:
13.5		 5w5vA-2r4bA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r8w AGR_C_1641P

(Agrobacterium
fabrum) 		PF00701
(DHDPS) 		5 LEU A 134
VAL A 138
GLY A  76
THR A  78
THR A 172
 None
None
ACT  A 333 (-3.5A)
ACT  A 333 (-3.5A)
None
 1.47A 5w5vA-2r8wA:
undetectable		 5w5vA-2r8wA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  68
ALA A  92
GLY A 147
THR A 151
THR A 204
 STU  A   1 (-3.8A)
STU  A   1 (-3.3A)
STU  A   1 ( 3.9A)
None
STU  A   1 (-3.6A)
 0.87A 5w5vA-2z7rA:
5.2		 5w5vA-2z7rA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  68
ALA A  92
VAL A 125
GLY A 147
THR A 204
 STU  A   1 (-3.8A)
STU  A   1 (-3.3A)
None
STU  A   1 ( 3.9A)
STU  A   1 (-3.6A)
 0.87A 5w5vA-2z7rA:
5.2		 5w5vA-2z7rA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z8c INSULIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LEU A1002
ALA A1028
VAL A1060
MET A1076
GLY A1082
MET A1139
 S91  A   1 ( 4.1A)
S91  A   1 (-3.2A)
None
S91  A   1 ( 4.9A)
S91  A   1 (-3.3A)
S91  A   1 ( 3.7A)
 0.61A 5w5vA-2z8cA:
11.2		 5w5vA-2z8cA:
18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a62 RIBOSOMAL PROTEIN S6
KINASE BETA-1

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  97
ALA A 121
GLY A 178
MET A 225
THR A 235
 STU  A 400 (-3.8A)
STU  A 400 (-3.1A)
STU  A 400 ( 4.4A)
STU  A 400 (-3.6A)
STU  A 400 (-4.4A)
 0.91A 5w5vA-3a62A:
14.0		 5w5vA-3a62A:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3amj ZINC PEPTIDASE
ACTIVE SUBUNIT

(Sphingomonas
sp. A1) 		no annotation 5 LEU C 240
ALA C 134
VAL C 218
MET C 130
GLY C 212
 None
 1.23A 5w5vA-3amjC:
undetectable		 5w5vA-3amjC:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hko CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE WITH A KINASE
DOMAIN AND 2
CALMODULIN-LIKE EF
HANDS

(Cryptosporidium
parvum) 		PF00069
(Pkinase) 		5 ALA A  37
MET A  89
CYH A  92
GLY A  94
THR A 119
 ANP  A 329 ( 3.7A)
ANP  A 329 (-3.7A)
ANP  A 329 (-4.1A)
None
None
 1.29A 5w5vA-3hkoA:
10.7		 5w5vA-3hkoA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hko CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE WITH A KINASE
DOMAIN AND 2
CALMODULIN-LIKE EF
HANDS

(Cryptosporidium
parvum) 		PF00069
(Pkinase) 		5 ALA A  37
VAL A 194
CYH A  92
GLY A  94
THR A 119
 ANP  A 329 ( 3.7A)
None
ANP  A 329 (-4.1A)
None
None
 1.06A 5w5vA-3hkoA:
10.7		 5w5vA-3hkoA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 833
ALA A 859
VAL A 892
CYH A 912
GLY A 915
 8ST  A2001 ( 4.7A)
8ST  A2001 ( 3.8A)
8ST  A2001 ( 4.7A)
8ST  A2001 (-3.8A)
None
 0.56A 5w5vA-3hngA:
11.4		 5w5vA-3hngA:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lw0 INSULIN-LIKE GROWTH
FACTOR 1 RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A1005
ALA A1031
VAL A1063
MET A1079
GLY A1085
 None
None
CCX  A   1 (-4.1A)
CCX  A   1 ( 3.9A)
None
 0.59A 5w5vA-3lw0A:
13.0		 5w5vA-3lw0A:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  49
ALA A  70
VAL A 104
MET A 120
GLY A 126
THR A 183
 XFE  A 351 (-4.2A)
XFE  A 351 (-3.2A)
None
XFE  A 351 ( 4.0A)
None
XFE  A 351 (-3.7A)
 0.87A 5w5vA-3mvjA:
13.1		 5w5vA-3mvjA:
20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n7t MACROPHAGE BINDING
PROTEIN

(Coccidioides
immitis) 		PF01965
(DJ-1_PfpI) 		5 LEU A 114
VAL A 107
MET A 146
GLY A 110
THR A  26
 None
 1.50A 5w5vA-3n7tA:
undetectable		 5w5vA-3n7tA:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qoy 50S RIBOSOMAL
PROTEIN L1

(Aquifex
aeolicus) 		PF00687
(Ribosomal_L1) 		5 LEU A 135
ALA A 118
GLY A 139
THR A 221
THR A 146
 None
 1.44A 5w5vA-3qoyA:
undetectable		 5w5vA-3qoyA:
17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  71
VAL A  98
MET A 118
GLY A 123
THR A 186
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
I85  A 350 (-4.3A)
I85  A 350 ( 4.0A)
 0.81A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  71
VAL A  98
MET A 118
GLY A 124
THR A 186
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.9A)
I85  A 350 (-3.0A)
I85  A 350 ( 4.0A)
 0.67A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  50
ALA A  71
VAL A  98
GLY A 124
THR A 186
 I85  A 350 (-3.7A)
I85  A 350 (-3.3A)
None
I85  A 350 (-3.0A)
I85  A 350 ( 4.0A)
 0.84A 5w5vA-3sheA:
4.2		 5w5vA-3sheA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vcr PUTATIVE KDPG
(2-KETO-3-DEOXY-6-PH
OSPHOGLUCONATE)
ALDOLASE

(Oleispira
antarctica) 		PF01081
(Aldolase) 		5 LEU A  23
ALA A  56
VAL A  66
GLY A  50
THR A  47
 None
 1.16A 5w5vA-3vcrA:
undetectable		 5w5vA-3vcrA:
16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 840
ALA A 866
VAL A 899
CYH A 919
GLY A 922
 4TT  A2001 ( 4.0A)
4TT  A2001 (-3.5A)
None
4TT  A2001 (-4.3A)
4TT  A2001 (-3.7A)
 0.42A 5w5vA-3vidA:
8.0		 5w5vA-3vidA:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wiw GLYCOSYL HYDROLASE
FAMILY 88

(Pedobacter
heparinus) 		PF07470
(Glyco_hydro_88) 		5 LEU A  94
ALA A  98
VAL A 131
GLY A  90
THR A 398
 None
 1.50A 5w5vA-3wiwA:
undetectable		 5w5vA-3wiwA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 840
ALA A 866
VAL A 899
CYH A 919
GLY A 922
 LEV  A1201 ( 3.8A)
LEV  A1201 (-3.5A)
None
LEV  A1201 (-4.1A)
LEV  A1201 (-3.6A)
 0.41A 5w5vA-3wzdA:
5.3		 5w5vA-3wzdA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zg8 PENICILLIN-BINDING
PROTEIN 4

(Listeria
monocytogenes) 		PF00905
(Transpeptidase)
PF00912
(Transgly) 		5 ALA B 400
VAL B 477
GLY B 490
THR B 579
MET B 491
 None
None
GOL  B1643 ( 4.9A)
GOL  B1643 (-4.3A)
None
 1.44A 5w5vA-3zg8B:
undetectable		 5w5vA-3zg8B:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 840
ALA A 866
VAL A 899
CYH A 919
GLY A 922
 B49  A2000 (-3.7A)
B49  A2000 (-3.5A)
B49  A2000 ( 4.6A)
B49  A2000 (-4.2A)
B49  A2000 ( 3.7A)
 0.40A 5w5vA-4agdA:
4.7		 5w5vA-4agdA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bc6 SERINE/THREONINE-PRO
TEIN KINASE 10

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  42
ALA A  63
VAL A  94
CYH A 113
GLY A 116
 XZN  A1317 (-3.6A)
XZN  A1317 (-3.5A)
XZN  A1317 (-4.4A)
XZN  A1317 (-3.7A)
XZN  A1317 ( 3.7A)
 0.80A 5w5vA-4bc6A:
4.9		 5w5vA-4bc6A:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 LEU A 663
ALA A 684
VAL A 721
MET A 737
GLY A 743
 AGS  A1985 (-4.2A)
AGS  A1985 (-3.5A)
None
AGS  A1985 (-4.2A)
None
 0.64A 5w5vA-4crsA:
14.8		 5w5vA-4crsA:
20.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4eut SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  15
ALA A  36
VAL A  68
MET A  86
CYH A  89
GLY A  92
THR A  96
MET A 142
THR A 156
 BX7  A 401 (-3.7A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-4.5A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.5A)
BX7  A 401 ( 4.7A)
BX7  A 401 (-3.9A)
IOD  A 402 ( 3.4A)
 0.58A 5w5vA-4eutA:
27.5		 5w5vA-4eutA:
70.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  15
ALA A  36
VAL A  68
MET A  86
CYH A  89
GLY A  92
THR A  96
MET A 142
THR A 156
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-3.7A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
BX7  A 401 ( 4.5A)
BX7  A 401 (-4.0A)
IOD  A 402 ( 3.5A)
 0.59A 5w5vA-4euuA:
24.0		 5w5vA-4euuA:
56.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f4p TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 377
ALA A 400
VAL A 433
MET A 448
GLY A 454
 0SB  A 701 ( 3.9A)
0SB  A 701 (-3.3A)
None
0SB  A 701 (-3.6A)
0SB  A 701 (-3.5A)
 0.68A 5w5vA-4f4pA:
13.4		 5w5vA-4f4pA:
16.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g34 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A 598
ALA A 619
VAL A 651
MET A 887
CYH A 890
 924  A1101 ( 4.1A)
924  A1101 (-3.5A)
924  A1101 (-4.6A)
924  A1101 (-3.7A)
924  A1101 (-3.9A)
 0.61A 5w5vA-4g34A:
15.1		 5w5vA-4g34A:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gl9 TYROSINE-PROTEIN
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 LEU A 855
ALA A 880
VAL A 911
MET A 929
GLY A 935
 IZA  A2001 (-3.7A)
IZA  A2001 (-3.4A)
None
IZA  A2001 (-4.4A)
IZA  A2001 (-3.3A)
 0.79A 5w5vA-4gl9A:
12.3		 5w5vA-4gl9A:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gv1 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 ALA A 177
MET A 227
GLY A 232
MET A 281
THR A 291
 0XZ  A 501 (-3.3A)
0XZ  A 501 (-3.8A)
None
0XZ  A 501 (-3.5A)
0XZ  A 501 ( 4.1A)
 1.06A 5w5vA-4gv1A:
4.5		 5w5vA-4gv1A:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gv1 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 LEU A 156
ALA A 177
GLY A 233
MET A 281
THR A 211
 0XZ  A 501 ( 4.1A)
0XZ  A 501 (-3.3A)
None
0XZ  A 501 (-3.5A)
0XZ  A 501 ( 4.0A)
 1.26A 5w5vA-4gv1A:
4.5		 5w5vA-4gv1A:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gv1 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		6 LEU A 156
ALA A 177
MET A 227
GLY A 233
MET A 281
THR A 291
 0XZ  A 501 ( 4.1A)
0XZ  A 501 (-3.3A)
0XZ  A 501 (-3.8A)
None
0XZ  A 501 (-3.5A)
0XZ  A 501 ( 4.1A)
 0.84A 5w5vA-4gv1A:
4.5		 5w5vA-4gv1A:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hvi TYROSINE-PROTEIN
KINASE JAK3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 828
ALA A 853
VAL A 884
MET A 902
GLY A 908
 19S  A1201 (-3.9A)
19S  A1201 (-3.3A)
None
19S  A1201 (-3.6A)
19S  A1201 ( 3.8A)
 0.69A 5w5vA-4hviA:
11.8		 5w5vA-4hviA:
18.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4jlc SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Mus musculus) 		PF00069
(Pkinase) 		8 ALA A  36
VAL A  68
MET A  86
CYH A  89
GLY A  92
THR A  96
MET A 142
THR A 156
 SU6  A 701 (-3.4A)
None
SU6  A 701 (-3.4A)
SU6  A 701 (-3.8A)
SU6  A 701 (-3.8A)
SU6  A 701 (-2.9A)
SU6  A 701 (-4.2A)
SU6  A 701 (-3.5A)
 0.63A 5w5vA-4jlcA:
37.5		 5w5vA-4jlcA:
93.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4jlc SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Mus musculus) 		PF00069
(Pkinase) 		8 LEU A  15
ALA A  36
VAL A  68
CYH A  89
GLY A  92
THR A  96
MET A 142
THR A 156
 SU6  A 701 (-3.6A)
SU6  A 701 (-3.4A)
None
SU6  A 701 (-3.8A)
SU6  A 701 (-3.8A)
SU6  A 701 (-2.9A)
SU6  A 701 (-4.2A)
SU6  A 701 (-3.5A)
 0.53A 5w5vA-4jlcA:
37.5		 5w5vA-4jlcA:
93.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lg4 SERINE/THREONINE-PRO
TEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  33
ALA A  54
VAL A  83
MET A  99
CYH A 102
GLY A 105
 GOL  A 404 ( 3.6A)
GOL  A 404 ( 3.1A)
GOL  A 403 (-4.1A)
GOL  A 403 (-2.7A)
GOL  A 403 (-4.0A)
GOL  A 404 (-3.6A)
 0.59A 5w5vA-4lg4A:
11.1		 5w5vA-4lg4A:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mpt PUTATIVE
LEU/ILE/VAL-BINDING
PROTEIN

(Bordetella
pertussis) 		PF13458
(Peripla_BP_6) 		5 ALA A 128
VAL A 109
GLY A  78
THR A   9
MET A  85
 None
 1.49A 5w5vA-4mptA:
undetectable		 5w5vA-4mptA:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mvf CALCIUM-DEPENDENT
PROTEIN KINASE 2

(Plasmodium
falciparum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 LEU A  78
ALA A  99
MET A 146
CYH A 149
GLY A 151
 STU  A 601 ( 4.0A)
STU  A 601 (-3.3A)
STU  A 601 ( 4.3A)
STU  A 601 (-4.2A)
STU  A 601 (-3.4A)
 0.67A 5w5vA-4mvfA:
3.9		 5w5vA-4mvfA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mvf CALCIUM-DEPENDENT
PROTEIN KINASE 2

(Plasmodium
falciparum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 LEU A  78
ALA A  99
VAL A 130
MET A 146
CYH A 149
 STU  A 601 ( 4.0A)
STU  A 601 (-3.3A)
None
STU  A 601 ( 4.3A)
STU  A 601 (-4.2A)
 0.68A 5w5vA-4mvfA:
3.9		 5w5vA-4mvfA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o38 CYCLIN-G-ASSOCIATED
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  46
ALA A  67
VAL A  99
CYH A 126
GLY A 128
 SIN  A 401 ( 3.9A)
SIN  A 401 ( 3.7A)
None
SIN  A 401 (-4.3A)
SIN  A 401 (-3.5A)
 0.45A 5w5vA-4o38A:
11.9		 5w5vA-4o38A:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4otd SERINE/THREONINE-PRO
TEIN KINASE N1

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 LEU A 627
ALA A 648
VAL A 685
MET A 701
GLY A 707
 None
 0.58A 5w5vA-4otdA:
13.9		 5w5vA-4otdA:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 616
ALA A 642
VAL A 675
CYH A 694
GLY A 697
 P30  A1001 (-3.8A)
P30  A1001 (-3.4A)
None
None
P30  A1001 (-3.4A)
 0.42A 5w5vA-4rt7A:
14.0		 5w5vA-4rt7A:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uie SURFACE LAYER
PROTEIN

(Geobacillus
stearothermophilus) 		no annotation 5 LEU A1022
ALA A1024
VAL A1061
GLY A1057
THR A1009
 None
 1.39A 5w5vA-4uieA:
undetectable		 5w5vA-4uieA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase)
PF00226
(DnaJ) 		6 LEU A 104
ALA A 125
VAL A 159
MET A 175
GLY A 181
THR A 238
 ATP  A 501 ( 4.3A)
ATP  A 501 (-3.4A)
None
ATP  A 501 (-3.6A)
None
ATP  A 501 (-3.1A)
 0.88A 5w5vA-4wb7A:
13.4		 5w5vA-4wb7A:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wbo RHODOPSIN KINASE

(Bos taurus) 		PF00069
(Pkinase)
PF00615
(RGS) 		5 LEU A 193
ALA A 214
VAL A 248
MET A 264
GLY A 270
 ANW  A 601 ( 4.0A)
ANW  A 601 (-3.4A)
None
ANW  A 601 (-3.2A)
ANW  A 601 ( 4.5A)
 0.71A 5w5vA-4wboA:
14.1		 5w5vA-4wboA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  52
ALA A  72
VAL A 104
MET A 126
CYH A 129
GLY A 132
 KSA  A 405 ( 4.0A)
KSA  A 405 (-3.2A)
None
KSA  A 405 ( 3.7A)
KSA  A 405 (-4.5A)
KSA  A 405 (-3.5A)
 0.59A 5w5vA-4wsqA:
14.0		 5w5vA-4wsqA:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xmr PUTATIVE
METHYL-ACCEPTING
CHEMOTAXIS SIGNAL
TRANSDUCTION PROTEIN

(Campylobacter
jejuni) 		PF02743
(dCache_1) 		5 LEU A  58
ALA A 274
VAL A 206
GLY A 211
THR A  64
 None
 1.46A 5w5vA-4xmrA:
undetectable		 5w5vA-4xmrA:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 616
ALA A 642
VAL A 675
CYH A 694
GLY A 697
 P30  A1001 (-4.0A)
P30  A1001 (-3.5A)
None
P30  A1001 (-4.2A)
P30  A1001 (-3.5A)
 0.55A 5w5vA-4xufA:
11.7		 5w5vA-4xufA:
17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bv9 CELLULOSE
1,4-BETA-CELLOBIOSID
ASE

(Bacillus
pumilus) 		PF02011
(Glyco_hydro_48) 		5 LEU A  71
ALA A 235
GLY A  62
THR A  65
THR A 691
 None
 1.45A 5w5vA-5bv9A:
undetectable		 5w5vA-5bv9A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ci7 SERINE/THREONINE-PRO
TEIN KINASE ULK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  44
VAL A  76
MET A  92
CYH A  95
GLY A  98
 51W  A 401 (-3.4A)
None
51W  A 401 (-3.9A)
51W  A 401 (-3.9A)
51W  A 401 (-3.7A)
 0.63A 5w5vA-5ci7A:
17.7		 5w5vA-5ci7A:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5enz UDP-GLCNAC
2-EPIMERASE

(Staphylococcus
aureus) 		PF02350
(Epimerase_2) 		5 ALA A  18
VAL A  34
GLY A   9
THR A  97
THR A   6
 None
None
None
TRS  A 403 ( 4.9A)
None
 1.42A 5w5vA-5enzA:
undetectable		 5w5vA-5enzA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 599
ALA A 625
VAL A 658
CYH A 677
GLY A 680
 748  A1001 (-3.8A)
748  A1001 (-3.7A)
748  A1001 ( 4.8A)
748  A1001 (-4.5A)
748  A1001 ( 4.0A)
 0.69A 5w5vA-5grnA:
13.6		 5w5vA-5grnA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  57
ALA A  77
VAL A 109
CYH A 133
GLY A 136
 IDV  A 401 (-3.8A)
IDV  A 401 (-3.6A)
None
IDV  A 401 (-4.6A)
IDV  A 401 (-3.4A)
 0.67A 5w5vA-5i3oA:
14.4		 5w5vA-5i3oA:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  43
VAL A  74
MET A  90
CYH A  93
GLY A  95
 6G2  A 901 (-3.2A)
None
6G2  A 901 (-3.5A)
TPO  A 145 (-4.1A)
TPO  A 145 ( 4.7A)
 0.97A 5w5vA-5j5tA:
9.7		 5w5vA-5j5tA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  43
VAL A  74
MET A  90
CYH A  93
GLY A  96
 6G2  A 901 (-3.2A)
None
6G2  A 901 (-3.5A)
TPO  A 145 (-4.1A)
6G2  A 901 (-3.6A)
 0.71A 5w5vA-5j5tA:
9.7		 5w5vA-5j5tA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 297
VAL A 328
MET A 344
GLY A 349
THR A 406
 IPW  A 601 (-3.5A)
None
IPW  A 601 (-3.5A)
None
IPW  A 601 (-3.7A)
 0.97A 5w5vA-5kbrA:
11.1		 5w5vA-5kbrA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 297
VAL A 328
MET A 344
GLY A 350
THR A 406
 IPW  A 601 (-3.5A)
None
IPW  A 601 (-3.5A)
IPW  A 601 ( 3.8A)
IPW  A 601 (-3.7A)
 0.44A 5w5vA-5kbrA:
11.1		 5w5vA-5kbrA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kkr KINASE SUPPRESSOR OF
RAS 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA B 690
VAL B 723
CYH B 742
GLY B 744
THR B 802
 6U7  B1001 (-3.6A)
None
6U7  B1001 (-3.5A)
None
6U7  B1001 (-3.6A)
 1.14A 5w5vA-5kkrB:
14.5		 5w5vA-5kkrB:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ko1 MIXED LINEAGE KINASE
DOMAIN-LIKE PROTEIN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 209
ALA A 228
MET A 283
CYH A 286
GLY A 289
 None
6UY  A 501 (-3.4A)
6UY  A 501 (-3.8A)
6UY  A 501 (-4.3A)
6UY  A 501 ( 4.3A)
 0.86A 5w5vA-5ko1A:
13.9		 5w5vA-5ko1A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l9w ACETOPHENONE
CARBOXYLASE ALPHA
SUBUNIT

(Aromatoleum
aromaticum) 		PF01968
(Hydantoinase_A)
PF05378
(Hydant_A_N) 		5 LEU b 330
ALA b 407
VAL b 275
GLY b 318
THR b 280
 None
 1.07A 5w5vA-5l9wb:
2.8		 5w5vA-5l9wb:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l9w ACETOPHENONE
CARBOXYLASE DELTA
SUBUNIT

(Aromatoleum
aromaticum) 		PF02538
(Hydantoinase_B) 		5 LEU A 415
VAL A 575
MET A 495
THR A 449
THR A 576
 None
 1.32A 5w5vA-5l9wA:
undetectable		 5w5vA-5l9wA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5loh SERINE/THREONINE-PRO
TEIN KINASE
GREATWALL,SERINE/THR
EONINE-PROTEIN
KINASE GREATWALL

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  60
VAL A  94
MET A 110
GLY A 115
THR A 173
 STU  A 901 (-3.3A)
None
STU  A 901 (-3.7A)
None
STU  A 901 (-3.5A)
 0.87A 5w5vA-5lohA:
15.0		 5w5vA-5lohA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5loh SERINE/THREONINE-PRO
TEIN KINASE
GREATWALL,SERINE/THR
EONINE-PROTEIN
KINASE GREATWALL

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  60
VAL A  94
MET A 110
GLY A 116
THR A 173
 STU  A 901 (-3.3A)
None
STU  A 901 (-3.7A)
STU  A 901 (-3.5A)
STU  A 901 (-3.5A)
 0.46A 5w5vA-5lohA:
15.0		 5w5vA-5lohA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ncl SERINE/THREONINE-PRO
TEIN KINASE CBK1

(Saccharomyces
cerevisiae) 		no annotation 5 ALA A 379
VAL A 413
MET A 429
GLY A 435
THR A 439
 ANP  A 801 ( 3.9A)
ANP  A 801 ( 4.9A)
ANP  A 801 ( 4.5A)
None
None
 0.72A 5w5vA-5nclA:
13.9		 5w5vA-5nclA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nth PUTATIVE
AMINOPEPTIDASE

(Leishmania
major) 		PF00883
(Peptidase_M17) 		5 VAL A 512
MET A 514
CYH A 457
GLY A 450
MET A 446
 None
 1.40A 5w5vA-5nthA:
undetectable		 5w5vA-5nthA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u94 SERINE/THREONINE-PRO
TEIN KINASE PKNB

(Mycobacterium
tuberculosis) 		no annotation 5 LEU A  17
ALA A  38
VAL A  72
GLY A  97
MET A 145
 G93  A 301 ( 3.8A)
G93  A 301 ( 3.7A)
G93  A 301 (-4.0A)
GOL  A 305 ( 4.3A)
G93  A 301 ( 3.7A)
 0.99A 5w5vA-5u94A:
5.4		 5w5vA-5u94A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vil MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 5

(Homo sapiens) 		no annotation 5 LEU A 686
ALA A 707
VAL A 738
MET A 754
GLY A 760
 9E1  A1001 (-3.7A)
9E1  A1001 (-3.5A)
9E1  A1001 (-4.1A)
9E1  A1001 (-2.8A)
9E1  A1001 (-3.4A)
 0.69A 5w5vA-5vilA:
14.1		 5w5vA-5vilA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vqh TUDOR AND KH
DOMAIN-CONTAINING
PROTEIN HOMOLOG

(Bombyx mori) 		PF00567
(TUDOR) 		5 LEU A 126
VAL A  18
CYH A 124
GLY A 191
THR A 174
 None
 1.42A 5w5vA-5vqhA:
undetectable		 5w5vA-5vqhA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wgc DAUNORUBICIN-DOXORUB
ICIN POLYKETIDE
SYNTHASE

(Streptomyces
peucetius) 		no annotation 5 LEU A 298
ALA A 305
VAL A 263
THR A 163
THR A 288
 None
None
None
AFY  A 401 (-3.4A)
None
 1.42A 5w5vA-5wgcA:
undetectable		 5w5vA-5wgcA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ao5 SERINE/THREONINE-PRO
TEIN KINASE 3

(Homo sapiens) 		no annotation 5 LEU A  33
ALA A  54
VAL A  83
CYH A 102
GLY A 105
 ANP  A 501 ( 3.8A)
ANP  A 501 ( 3.7A)
None
ANP  A 501 (-4.2A)
ANP  A 501 ( 4.0A)
 0.54A 5w5vA-6ao5A:
5.4		 5w5vA-6ao5A:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 5 ALA A 388
VAL A 422
MET A 438
CYH A 441
GLY A 443
 EE4  A 701 (-3.3A)
None
EE4  A 701 ( 3.8A)
EE4  A 701 (-4.6A)
None
 0.86A 5w5vA-6c0tA:
14.7		 5w5vA-6c0tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 6 LEU A 366
ALA A 388
VAL A 422
MET A 438
CYH A 441
GLY A 444
 EE4  A 701 ( 4.6A)
EE4  A 701 (-3.3A)
None
EE4  A 701 ( 3.8A)
EE4  A 701 (-4.6A)
None
 0.82A 5w5vA-6c0tA:
14.7		 5w5vA-6c0tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 6 LEU A 366
ALA A 388
VAL A 422
MET A 438
GLY A 444
THR A 448
 EE4  A 701 ( 4.6A)
EE4  A 701 (-3.3A)
None
EE4  A 701 ( 3.8A)
None
None
 1.04A 5w5vA-6c0tA:
14.7		 5w5vA-6c0tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 5 LEU A 376
ALA A 388
VAL A 422
MET A 438
CYH A 441
 None
EE4  A 701 (-3.3A)
None
EE4  A 701 ( 3.8A)
EE4  A 701 (-4.6A)
 1.25A 5w5vA-6c0tA:
14.7		 5w5vA-6c0tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c2j RNAP2

(Escherichia
virus N4) 		no annotation 5 LEU B  81
ALA B  94
VAL B 396
CYH B  86
THR B 244
 None
 1.49A 5w5vA-6c2jB:
undetectable		 5w5vA-6c2jB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cth CONCANAVALIN A-LIKE
LECTIN PROTEIN
KINASE FAMILY
PROTEIN

(Theobroma cacao) 		no annotation 5 LEU A 275
ALA A 296
VAL A 327
GLY A 349
MET A 400
 FE7  A 601 (-3.8A)
FE7  A 601 (-3.3A)
None
FE7  A 601 ( 3.7A)
FE7  A 601 (-3.8A)
 0.89A 5w5vA-6cthA:
12.3		 5w5vA-6cthA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cyz HOMOSERINE KINASE

(Mycobacteroides
abscessus) 		no annotation 5 LEU A 255
ALA A 273
GLY A 259
MET A 229
THR A 232
 None
 1.31A 5w5vA-6cyzA:
undetectable		 5w5vA-6cyzA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fdy -

(-) 		no annotation 5 ALA U  42
VAL U  75
MET U  91
CYH U  94
GLY U  96
 DB8  U 301 (-3.6A)
DB8  U 301 (-4.8A)
DB8  U 301 (-4.8A)
DB8  U 301 (-4.2A)
None
 1.05A 5w5vA-6fdyU:
4.1		 5w5vA-6fdyU:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fdy -

(-) 		no annotation 6 LEU U  20
ALA U  42
VAL U  75
MET U  91
CYH U  94
GLY U  97
 DB8  U 301 (-3.7A)
DB8  U 301 (-3.6A)
DB8  U 301 (-4.8A)
DB8  U 301 (-4.8A)
DB8  U 301 (-4.2A)
DB8  U 301 ( 4.1A)
 0.74A 5w5vA-6fdyU:
4.1		 5w5vA-6fdyU:
undetectable